Delta-Fly Pharma, Inc. (TYO:4598)

Delta-Fly Pharma Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	145	338	1,417	844	1,268
Cash & Short-Term Investments	145	338	1,417	844	1,268
Cash Growth	-57.10%	-76.15%	67.89%	-33.44%	-39.27%
Other Receivables	57	51	-	-	-
Receivables	57	51	-	-	-
Prepaid Expenses	3	2	2	3	5
Other Current Assets	2	3	13	19	7
Total Current Assets	207	394	1,432	866	1,280
Property, Plant & Equipment	35	36	38	38	39
Long-Term Investments	3	2	2	1	3
Other Long-Term Assets	1	2	2	1	2
Total Assets	246	434	1,474	906	1,324
Current Income Taxes Payable	210	154	238	113	89
Other Current Liabilities	2	2	3	2	2
Total Current Liabilities	212	156	241	115	91
Other Long-Term Liabilities	1	2	2	1	1
Total Liabilities	213	158	243	116	92
Common Stock	5,804	5,113	4,731	3,795	3,352
Additional Paid-In Capital	5,784	5,093	4,711	3,775	3,332
Retained Earnings	-11,557	-9,931	-8,210	-6,780	-5,451
Comprehensive Income & Other	2	1	-1	-	-1
Shareholders' Equity	33	276	1,231	790	1,232
Total Liabilities & Equity	246	434	1,474	906	1,324
Net Cash (Debt)	145	338	1,417	844	1,268
Net Cash Growth	-57.10%	-76.15%	67.89%	-33.44%	-39.27%
Net Cash Per Share	12.53	38.41	197.05	148.95	234.09
Filing Date Shares Outstanding	12.49	9.71	8.22	6.29	5.42
Total Common Shares Outstanding	12.49	9.71	8.22	6.29	5.42
Working Capital	-5	238	1,191	751	1,189
Book Value Per Share	2.64	28.42	149.72	125.68	227.33
Tangible Book Value	33	276	1,231	790	1,232
Tangible Book Value Per Share	2.64	28.42	149.72	125.68	227.33

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error